adaptive biotechnologies stock forecast
Down from US5000 the current price target is an average from 7 analysts. Adaptive Biotechnologies stock was trading at 2152 on March 11th 2020 when COVID-19 Coronavirus reached pandemic status according to the World Health Organization.
Pin On My Saves
Ad Explore the Latest Features Tools to Become a More Strategic Trader.
. Adaptive Biotechnologies Corp is in the bottom half of stocks. That ADAPTIVE BIOTECHNOLOGIESs share price could reach 3000 by Feb 16 2023. 286 rows About the Adaptive Biotechnologies Corp.
Adaptive Biotechnologies releases earnings for Q2 on August 4. Learn How to Make Your Saving Goals a Reality. Find Out What Services a Dedicated Financial Advisor Offers.
The Wall Street analyst predicted. Ad Get the Inside Access Traders Are Using to Profit More and Win Bigger. The average Adaptive Biotechnologies stock forecast 2022 represents a 127 increase from the last price of 108199996948242.
Real time Adaptive Biotechnologies Corporation ADPT stock price quote stock graph news analysis. Since its inception the company has been a loss-maker. Based on 5 Wall Street analysts offering 12 month price targets for Adaptive Biotechnologies in the last 3 months.
ADPT stock is down over 72 in the previous 52-weeks and 585 YTD. The average price target is 2420 with a high forecast of 3200 and a low. Find the latest Adaptive Biotechnologies Corporation ADPT stock quote history news and other vital information to help you with your stock trading and investing.
ADPT Delayed Price USD. 136 1977 At close. Adaptive Biotechnologies Corporation ADPT NASDAQ.
These share price targets forecast are valid from short-term to mid-term to long-term. Smart Technology for Confident Trading. The 5 analysts offering 12-month price forecasts for Adaptive Biotechnologies Corp have a median target of 1800 with a high estimate of 2500 and a low.
Adaptive Biotechnologies Corporation ADPT share price prediction for 2022 2023 2024 2025 2026 and 2027. Adaptive Biotechnologies Corp. According to 13 stock.
Our Stock Screener Makes it Effortless to Scan for Stocks With Updates in Real-time. Adaptive Biotechnologies stock. InvestorsObserver gives Adaptive Biotechnologies Corp ADPT an overall rank of 40 which is below average.
NASDAQ stock ADPT Adaptive Biotechnologies forecast share price targets are below. The average ADAPTIVE BIOTECHNOLOGIES stock price prediction. Adaptive Biotechnologies Corp Stock Price Forecast ADPT Predictons for2022.
Backed By 30 Years Of Experience. 8 analysts forecast losses of 0415 per share as opposed to losses of 0260 in the same quarter of the. Find real-time ADPT - Adaptive Biotechnologies Corp stock quotes company profile news and forecasts from CNN Business.
New target price is 276 above last closing price of US851. Adaptive Biotechnologies Corp Stock Forecast and Price Prognosis Data for 2022. The company has developed an immune medicine platform for the diagnosis and treatment of.
Adaptive Biotechnologies ADPT stock price revenue and financials. Ad Searching for Financial Security. Its stock closed at.
Stock is down 80 over the past year. Adaptive Biotechnologies is a medical diagnostic firm located in Seattle WA. Adaptive Biotechnologies closed up more than 100 at 4030 a share on its first trading day making it at the time in the top five IPO debuts of the year.
This would be a huge 38 improvement in sales. As of 2022 May 07 Saturday current price of ADPT stock is 8230 and our data indicates that the asset. 7 analysts forecast losses of 0452 per share as opposed to losses of 0330 in.
Following the latest results Adaptive Biotechnologiess five analysts are now forecasting revenues of US1175m in 2020. Adaptive Biotechnologies market cap is 12 b and annual revenue was 9838 m in FY 2020. ADPT one year forecast.
ADPT stock forecast Our latest prediction for Adaptive Biotechnologies Corps stock price was made on the March 9 2022 when the stock price was at 1282. For Adaptive Biotechnologies stock forecast for 2023 12. According to the issued ratings of 7 analysts in the last year the consensus rating for Adaptive Biotechnologies stock is Buy based on the current 2 hold ratings and 5 buy.
Adaptive Biotechnologies will report earnings from the most recent quarter on February 15.
Adaptive Biotechnologies Good Buy For Long Term Investors Adpt Newzsite
Adaptive Biotechnologies Good Buy For Long Term Investors Adpt Newzsite
Adaptive Biotechnologies Funding Financials Valuation Investors
Adaptive Biotechnologies Corp Shares Fall 6 2 Below Previous 52 Week Low Market Mover Nasdaq
Adaptive Biotechnologies Good Buy For Long Term Investors Adpt Seeking Alpha
Adaptive Biotechnologies Good Buy For Long Term Investors Adpt Seeking Alpha
Adaptive Biotechnologies Good Buy For Long Term Investors Adpt Seeking Alpha
Adaptive Biotechnologies Good Buy For Long Term Investors Adpt Seeking Alpha
Adaptive Biotechnologies Good Buy For Long Term Investors Adpt Newzsite
How Many Adaptive Biotechnologies Corporation Nasdaq Adpt Shares Do Institutions Own
Adaptive Biotechnologies Corp Share Price Usd0 0001
We Re Not Very Worried About Adaptive Biotechnologies Nasdaq Adpt Cash Burn Rate
Adaptive Biotechnologies Company Profile Stock Performance Earnings Pitchbook
Adaptive Biotechnologies Stock Soars 90 After Ringing Nasdaq Opening Bell Following 300m Ipo Geekwire
Bears Are Losing Control Over Adaptive Biotechnologies Adpt Here S Why It S A Buy Now Nasdaq
Adaptive Biotechnologies Becomes Oversold Adpt Nasdaq
Adaptive Biotechnologies Nasdaq Adpt Shareholders Incur Further Losses As Stock Declines 4 1 This Week Taking One Year Losses To 54 Nasdaq
Adaptive Biotechnologies Appoints Tycho Peterson As Chief Financial Officer Reorganizes And Streamlines Workforce To Drive Growth In Two Key Business Areas
Adpt Adaptive Biotechnologies Stock Price